North America Blood Irradiation Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Intravenous Laser Blood Irradiation, Transcutaneous Laser Blood Irradiation, and Extracorporeal Blood Irradiation), Indication (Acute Leukemia, Lymphoma, Solid Tumors, Pelvic Tumors, and Others), and End User (Hospitals, Blood Banks, Diagnostics Clinics, and Research Institutes)
The blood irradiation market in North America is expected to grow from US$ 29.02 million in 2022 to US$ 42.61 million by 2028. It is estimated to grow at a CAGR of 6.6% from 2022 to 2028.
Increase in Communicable and Noncommunicable Disease Prevalence Favors North America Blood
Irradiation Market Growth
In North America, there has been a rise in the incidence of blood transfusion procedures owing to the surge in surgical procedures, accidents, trauma cases, and disorders; and the rising prevalence of bloodstream infections. Bloodstream infections are the major cause of illness and death among large populations. Bloodstream infections, as well as underlying conditions, and invasive procedures are common among the geriatric population. The rising awareness about these infections and elevated immune response to transfused blood can lead to complications. There is a high prevalence of communicable and noncommunicable diseases, including cancer, cardiovascular disorders, chronic renal disease, and stroke, in North American countries. Blood transfusion may be a common step adopted during the treatment of these diseases. Cellular blood components are irradiated before undertaking the transfusion process. The irradiation prevents transfusion associated-graft versus host disease (TA-GVHD) among recipients by averting the proliferation of viable T lymphocytes. The increasing use of irradiated blood for the treatment of cancer patients strengthens the immune system and improves overall health.
Market Overview
The North American blood irradiation market has been segmented into the US, Canada, and Mexico. The US held the largest share of the market in 2022. The US accounts for a significant share of the blood irradiation market in North America. Increasing demand for organ transplantation followed by increasing prevalence of both communicable and non-communicable diseases is likely to increase the demand for blood irradiation market. The four major diseases responsible for the death in the United States are Cardiovascular diseases, Diabetes, Cancer and Chronic respiratory diseases. Thus, the increasing research and development in the country is anticipated to boost the US blood irradiation market growth during the forecast period.
North America Blood Irradiation Market Revenue and Forecast to 2028 (US$ Million)
North America Blood Irradiation Market Segmentation
The North America blood irradiation market is segmented into type, indication, end user, and country.
- Based on type, the market is segmented into intravenous laser blood irradiation, transcutaneous laser blood irradiation, and extracorporeal blood irradiation. The intravenous laser blood irradiation segment registered the largest market share in 2022.
- Based on indication, the North America blood irradiation market is segmented into acute leukemia, lymphoma, solid tumors, pelvic tumors, and others. The acute leukemia segment held the largest market share in 2022.
- Based on end user, the market is segmented into hospitals, blood banks, diagnostics clinics, and research institutes. The hospital segment held the largest market share in 2022.
- Based on country, the North America blood irradiation market is segmented into the US, Canada, Mexico; the US dominated the market in 2022.
Hitachi, Ltd.; Best Theratronics Ltd.; Rad Source Technologies; Gilardoni S.p.A.; Typenex Medical, and Actemium are the leading companies operating in the blood irradiation market in the region.
1. Introduction
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Blood Irradiation Market – By Type
1.3.2 North America Blood Irradiation Market – By Indication
1.3.3 North America Blood Irradiation Market – By End User
1.3.4 North America Blood Irradiation Market – By Country
2. North America Blood Irradiation Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Blood Irradiation Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.3 Experts Opinion
5. North America Blood Irradiation Market– Key Market Dynamics
5.1 Market Drivers
5.1.1 Increase in Communicable and Noncommunicable Diseases
5.1.2 Rise in Healthcare Expenditure and Government Initiatives
5.2 Market Restraints
5.2.1 Stringent Regulatory Policies, High Cost, and Challenges with Blood Component Irradiation
5.3 Market Opportunities
5.3.1 Increasing Immunocompromised Population and Rising Incidences of Leukemia and Lymphoma
5.4 Future Trends
5.4.1 Technological Advancements and Product Launches
5.5 Impact Analysis
6. Blood Irradiation Market– North America Analysis
6.1 North America Blood Irradiation Market Revenue Forecasts and Analysis
6.1.1 Overview
6.1.2 North America Blood Irradiation Market, and Forecast to 2028 (Units)
7. North America Blood Irradiation Market Analysis – By Type
7.1 Overview
7.2 North America Blood Irradiation Market Revenue Share, by Type (2021 and 2028)
7.2.1 North America: Blood Irradiation Market, by Type, 2019–2028 (US$ Million)
7.3 Intravenous Laser Blood Radiation
7.3.1 Overview
7.3.2 North America Intravenous Laser Blood Radiation: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Transcutaneous Laser Blood Radiation
7.4.1 Overview
7.4.2 North America Transcutaneous Laser Blood Radiation: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Extracorporeal Blood Radiation
7.5.1 Overview
7.5.2 North America Extracorporeal Blood Radiation: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
8. North America Blood Irradiation Market –By End User
8.1 Overview
8.2 North America Blood Irradiation Market, by End User, 2021 and 2028 (%)
8.2.1 North America: Blood Irradiation Market, by End-Users, 2019–2028 (US$ Million)
8.3 Hospitals
8.3.1 Overview
8.3.2 North America Hospitals: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Blood Banks
8.4.1 Overview
8.4.2 North America Blood Banks: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Diagnostic Centers
8.5.1 Overview
8.5.2 North America Diagnostic Centers: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Research Institutes
8.6.1 Overview
8.6.2 North America Research Institutes: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
9. North America Blood Irradiation Market –By Indication
9.1 Overview
9.2 North America Blood Irradiation Market, by Indication, 2021 and 2028 (%)
9.2.1 North America: Blood Irradiation Market, by Indication, 2019–2028 (US$ Million)
9.3 Acute Leukemia
9.3.1 Overview
9.3.2 North America Acute Leukemia: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Solid Tumors
9.4.1 Overview
9.4.2 North America Solid Tumors: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Pelvic Tumors
9.5.1 Overview
9.5.2 North America Pelvic Tumors: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Lymphoma
9.6.1 Overview
9.6.2 North America Lymphoma: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
9.7 Others
9.7.1 Overview
9.7.2 North America Others: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
10. North America Blood Irradiation Market – Country Analysis
10.1 North America: Blood Irradiation Market
10.1.1 Overview
10.1.2 North America: Blood Irradiation Market, by Country, 2021 & 2028 (%)
10.1.2.1 US: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.1.1 Overview
10.1.2.1.2 US: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.1.3 US: Blood Irradiation Market, by Type, 2019–2028 (US$ Million)
10.1.2.1.4 US: Blood Irradiation Market, by End-Users, 2019–2028 (US$ Million)
10.1.2.1.5 US: Blood Irradiation Market, by Indication, 2019–2028 (US$ Million)
10.1.2.2 Canada: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.2.1 Overview
10.1.2.2.2 Canada: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.2.3 Canada: Blood Irradiation Market, by Type, 2019–2028 (US$ Million)
10.1.2.2.4 Canada: Blood Irradiation Market, by End-Users, 2019–2028 (US$ Million)
10.1.2.2.5 Canada: Blood Irradiation Market, by Indication, 2019–2028 (US$ Million)
10.1.2.3 Mexico: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.3.1 Overview
10.1.2.3.2 Mexico: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.3.3 Mexico: Blood Irradiation Market, by Type, 2019–2028 (US$ Million)
10.1.2.3.4 Mexico: Blood Irradiation Market, by End-Users, 2019–2028 (US$ Million)
10.1.2.3.5 Mexico: Blood Irradiation Market, by Indication, 2019–2028 (US$ Million)
11. North America Blood Irradiation Market–Industry Landscape
11.1 Overview
11.2 Growth Strategies in the North America Blood Irradiation Market, 2021-2028
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Hitachi, Ltd.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Best Theratronics Ltd.,
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Rad Source Technologies
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Gilardoni S.p.A.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Typenex Medical
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Actemium
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Blood Irradiation Market– Volume and Forecast to 2028 (Units)
Table 2. North America Blood Irradiation Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 3. North America: Blood Irradiation Market, by End-Users – Revenue and Forecast to 2028 (US$ Million)
Table 4. North America Blood Irradiation Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 5. US Blood Irradiation Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 6. US Blood Irradiation Market, by End-Users – Revenue and Forecast to 2028 (US$ Million)
Table 7. US Blood Irradiation Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 8. Canada Blood Irradiation Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 9. Canada Blood Irradiation Market, by End-Users – Revenue and Forecast to 2028 (US$ Million)
Table 10. Canada Blood Irradiation Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 11. Mexico Blood Irradiation Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 12. Mexico Blood Irradiation Market, by End-Users – Revenue and Forecast to 2028 (US$ Million)
Table 13. Mexico Blood Irradiation Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 14. Recent Inorganic Growth Strategies in the Blood Irradiation Market
Table 15. Recent Organic Growth Strategies in the Blood Irradiation Market
Table 16. Glossary of Terms, Blood Irradiation Market
LIST OF FIGURES
Figure 1. North America Blood Irradiation Market Segmentation
Figure 2. North America Blood Irradiation Market Segmentation, By Region
Figure 3. North America Blood Irradiation Market Overview
Figure 4. Intravenous Laser Blood Irradiation Segment Held Largest Share of Type Segment in Blood Irradiation Market
Figure 5. Canada is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. North America: PEST Analysis
Figure 7. Experts Opinion
Figure 8. North America Blood Irradiation Market Impact Analysis of Drivers and Restraints
Figure 9. North America Blood Irradiation Market – Revenue Forecasts and Analysis – 2020- 2028
Figure 10. North America Blood Irradiation Market Revenue Share, by Type (2021 and 2028)
Figure 11. North America Intravenous Laser Blood Radiation: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. North America Transcutaneous Laser Blood Radiation: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. North America Extracorporeal Blood Radiation: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. North America Blood Irradiation Market, by End User, 2021 and 2028 (%)
Figure 15. North America Hospitals: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. North America Blood Banks: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. North America Diagnostic Centers: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. North America Research Institutes: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. North America Blood Irradiation Market, by Indication, 2021 and 2028 (%)
Figure 20. North America Acute Leukemia: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. North America Solid Tumors: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. North America Pelvic Tumors: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. North America Lymphoma: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. North America Others: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. North America: Blood Irradiation Market, by Key Country – Revenue (2021) (US$ ‘Million)
Figure 26. North America: Blood Irradiation Market, by Country, 2021 & 2028 (%)
Figure 27. US: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Canada: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Mexico: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. Growth Strategies in the North America Blood Irradiation Market, 2021-2028
- Hitachi, Ltd.
- Best Theratronics Ltd.,
- Rad Source Technologies
- Gilardoni S.p.A.
- Typenex Medical
- Actemium
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America Blood Irradiation Market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in North America Blood Irradiation Market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.